See also this year's filing and all EDGAR filings for this company.
PDF Report 0001506251_2026_Citius_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001506251, Citius Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 27,934,473 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,346,796 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 93,656,756 |
| 4 | LiabilitiesCurrent | 44,914,740 |
| 5 | LiabilitiesNoncurrent | 724,925 |
| 6 | remainder_Liabilities | 7,770,760 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,730,802 |
| 9 | ResearchAndDevelopmentExpense | 9,429,922 |
| 10 | remainder_Expenses | 11,474,813 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 79,476 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 130,938,025 |
| 1 | Liabilities | 53,410,425 |
| 2 | Expenses | 39,635,537 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 77,527,600 |
| 5 | NetIncome | -39,556,061 |
| 6 | ComprehensiveNetIncome | -39,556,061 |
| 7 | BaseVar | 112,031,732 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.40 |
| 9 | EconomicCapitalRatio | 2.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
